
Polyhedron p. 969 - 976 (1998)
Update date:2022-08-03
Topics:
Wheeler, Dale E.
Wu, Ji-Fang
Maatta, Eric A.
Reactions of the p-tolylimido vanadium(V) complex [V(NTol)Cl3], 1, with sodium dithiocarbamate salts Na[S2CNR2] yield an homologous series of organoimido vanadium(V) dithiocarbamate systems [TolN≡V(S2CNR2)xCl(3-x)] [x = 1 : R = Et (2a), Me (2b) ; x = 2 : R = Et (3a), Me (3b) ; x = 3 : R = Et (4a), Me (4b)]; the electronic and 51V NMR spectra of these complexes are described. Zn reduction of complexes 3 affords impure products whose ESR spectra are consistent with the presence of the V(IV) systems [V(NTol) (S2CNR2)2], 5. Reaction of VOCl3 with 0.5 equiv. of p-OCN - C6H4 - NCO yields the p-phenylenediimido complex [Cl3V≡NC6H4N=VCl3], 6. Dissolution of 6 in THF produces an adduct [(THF)3Cl3V≡ NC6H4N≡VCl3(THF)3], 7, whose THF ligands are weakly bound. VOCl3 reacts with an equimolar amount of p-OCN - C6H4 - NCO to produce the mononuclear complex p-[Cl3V≡NC6H4 - NCO], 8. The reaction of 8 with OWCl4 in refluxing toluene affords an insoluble product analyzing as the expected heterobinuclear system [Cl3V≡NC6H4N≡WCl4], 9, but treatment of this product with THF yields a mixture shown by 1H NMR to contain both 7 and its ditungsten analogue [(THF)Cl4W≡NC6H4N≡WCl 4(THF)], indicating that an unusual intermetallic exchange of imido ligands has occurred. The chloride ligands of 6 can be substituted by [S2CNEt2] or [OtBu] anions to afford [(Et2NCS2)3V≡NC6H 4N≡V(S2CNEt2)3], 11, and [(tBuO)3V≡NC6H 4N≡V(OtBu)3], 12, respectively.
Tianjin Boron PharmaTech Co.,Ltd.(expird)
Contact:86-022-59845187
Address:B9-401, Tianda Science Park,No.80,4th Avenue,TEDA,Tianjin, China
SHAANXI TOP PHARM CHEMICAL CO.LTD
Contact:+86-029-85733403
Address:No.108 ,west sector,south er huan,xi'an,china
Tianjin Hedong Red Cliff Chemical Reagent Factory
Contact:+86-022-84780548
Address:Li Ming Zhuang Gong Ye Yuan,Dongli District,Tianjin,China
Contact:+86-27-87204219, +86-27-87215023
Address:2402, HuiGu Space-time Building, 8 Forest Road, East Lake Hi-Tech Development Zone
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Doi:10.1021/jm025513q
(2003)Doi:10.1016/S0040-4039(98)00597-8
(1998)Doi:10.1016/j.molstruc.2021.130566
(2021)Doi:10.1039/c1dt10490j
(2011)Doi:10.1021/acs.joc.6b03037
(2017)Doi:10.1016/S0040-4039(96)02295-2
(1997)